Market insight in association witH

Study on robotic breast surgery has encouraging results

Nipple-sparing mastectomy (NSM) is a type of surgery used to reduce the risk of breast cancer development in high-risk patients with minimal scarring and satisfactory cosmetic results.


To determine the benefits of using robotic systems for NSM compared to traditional open surgical techniques, physicians at the European Institute of Oncology recently published a study consisting of 73 women who underwent robotic NSM (RNSM) between 2014 and 2019. Indications for surgery included invasive breast cancer, ductal carcinoma in situ (DCIS), or carrying the BRCA mutation without a cancer diagnosis.


The results of the study indicate that RNSM is associated with a number of benefits to both surgeons and patients, compared to traditional open mastectomy procedures. Benefits to surgeons include enhanced visualisation and access to areas of the breast tissue that are difficult to reach. This is a result of robotic arms being able to access tissue at angles that are not possible using retractors for open surgery. In turn, the enhanced incision range of robotic arms allows for more favourable cosmetic outcomes. Therefore, patients were more satisfied with the results of their surgeries. Furthermore, the complication rates, relapse rates, disease-free survival, and overall survival after RNSM were comparable to open surgery.


However, RNSM took more than an hour longer to perform compared to open surgery. The RNSM procedures lasted around 3.5 hours, while open mastectomies were completed in an average of 2.25 hours. This extra time will be associated with additional costs for NSM.


In 2019 GlobalData estimated the market for robotic surgical systems and disposable components to be $3B in the US and growing at a Compound Annual Growth Rate of 10.6%. Currently, robotic surgery for a mastectomy is not approved by the FDA due to limited data on safety and effectiveness. However, the rising popularity of robotic surgery is likely to stimulate additional studies to assess the benefits of RNSM and to determine if this technique is worth the increased costs associated with this technology.

For more insight and data, visit the GlobalData Report Store.

Go to article: Home | The new face of plastic surgery Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: In This Issue Go to article: NSFGo to article: ContentsGo to article: Equflow Company Insight Go to article: Equflow Go to article: NewsGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: The Medical Industry BriefingGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: How is technology transforming facial reconstruction surgery? Go to article: General PlasticsGo to article: Messe Stuttgart Go to article: Spider silk: a sticky solution to traditional sutures Go to article: Electronic Sensor TechnologyGo to article: Diverse diagnostics: why ‘one size fits all’ doesn’t always work Go to article: confinis Company Insight Go to article: confinisGo to article: 3D-printed living skin: the future of skin grafts?Go to article: Regulatory Globe Company Insight Go to article: Regulatory GlobeGo to article: From ECT to tDCS: how can brain stimulation treat mental illness?Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Devices are not drugs: rethinking medical device regulation in IndiaGo to article: ElectroCraftGo to article: Genome sequencing at birth: sophisticated care or ethical nightmare?Go to article: TS Quality & EngineeringGo to article: Back to compliance: MDIC extends a helping hand to struggling manufacturers Go to article: Watlow Company Insight Go to article: WatlowGo to article: Oxygen-affinity modulator for sickle cell disease to generate $1.8bn sales by 2025Go to article: ProByLas Go to article: Abbott’s Tendyne becomes first transcatheter mitral valve implantation device to receive CE markGo to article: Industrial Indexing Systems Company Insight Go to article: Industrial Indexing SystemsGo to article: FDA approves Eko cardiology technology advancesGo to article: STSGo to article: New standards for advancing AI capabilities in healthcare releasedGo to article: FargoGo to article: Study on robotic breast surgery has encouraging resultsGo to article: GF Machining Solutions Company InsightGo to article: GF Machining Solutions Go to article: Deals in brief powered by GlobaldataGo to article: The key list powered by GlobaldataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next Issue